Bridgeway Capital Management’s Amedisys AMED Stock Holding History

Bridgeway Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,310	Closed	-$1.29M	–	1388
2016 Q4	$1.29M	Sell	30,310 -51,750	-63%	-$2.2M	0.02%	709
2016 Q3	$3.89M	Hold	82,060	–	–	0.06%	294
2016 Q2	$4.14M	Buy	82,060 +27,250	+50%	+$1.38M	0.06%	279
2016 Q1	$2.65M	Sell	54,810 -82,850	-60%	-$3.2M	0.04%	408
2015 Q4	$5.41M	Sell	137,660 -350	-0.3%	-$14K	0.1%	202
2015 Q3	$5.24M	Sell	138,010 -30,000	-18%	-$1.27M	0.11%	194
2015 Q2	$6.67M	Hold	168,010	–	–	0.13%	170
2015 Q1	$4.5M	Buy	168,010 +350	+0.2%	+$9.88K	0.09%	246
2014 Q4	$4.92M	Sell	167,660 -66,300	-28%	-$1.64M	0.11%	201
2014 Q3	$4.72M	Hold	233,960	–	–	0.12%	197
2014 Q2	$3.92M	Hold	233,960	–	–	0.1%	248
2014 Q1	$3.48M	Buy	233,960 +30,000	+15%	+$462K	0.1%	261
2013 Q4	$2.98M	Buy	203,960 +116,900	+134%	+$1.88M	0.09%	308
2013 Q3	$1.5M	Hold	87,060	–	–	0.05%	547
2013 Q2	$1.01M	Buy	+87,060	New	+$997K	0.04%	624

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bridgeway Capital Management's AMED Position: Q1 2017 in Review

Bridgeway Capital Management sold out of Amedisys (AMED) in Q1 2017, closing a stake of 30,310 shares — an estimated $1.29M sold.

Bridgeway Capital Management first reported a position in AMED in Q2 2013 and held it in 15 quarters. The position peaked at $6.67M in Q2 2015. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

Bridgeway Capital Management reported no remaining Amedisys position as of Q1 2017 after selling out during the quarter.
Bridgeway Capital Management sold 30,310 Amedisys shares in Q1 2017, an estimated $1.29M.
Bridgeway Capital Management first reported a position in Amedisys in Q2 2013 and held it in 15 quarters.
Bridgeway Capital Management's Amedisys position peaked at $6.67M in Q2 2015.
152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Bridgeway Capital Management's 13F filing for Q1 2017, filed 15 May 2017.